Jazz Pharmaceuticals plc (JAZZ) insider trading.
In Q3 2026, insiders at Jazz Pharmaceuticals plc reported 57 non-derivative transactions on 34 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $24.4M.
- Transactions
- 57
- Purchases (P)
- 0
- Sales (S)
- 11
- Net shares, P minus S
- -98,121
- Insiders
- 17
- Last filed
- 2026-09-14
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Iannone Robert | Officer · EVP, Global Head of R&D & CMO | 11 | 0 | 6 |
| Cozadd Bruce C | Director | 6 | 0 | 3 |
| Henderson Mary Elizabeth | Officer · SVP, Technical Operations | 4 | 0 | 0 |
| Gala Renee D | Officer · President & CEO | 3 | 0 | 1 |
| Riedel Norbert G | Director | 3 | 0 | 0 |
| Love Ted W | Director | 3 | 0 | 0 |
| Enright Patrick G | Director | 3 | 0 | 0 |
| Winningham Rick E | Director | 3 | 0 | 0 |
| McSharry Heather Ann | Director | 3 | 0 | 0 |
| Hamill Laura | Director | 3 | 0 | 0 |
| Cook Jennifer E. | Director | 3 | 0 | 0 |
| Smith Mark Douglas | Director | 3 | 0 | 0 |
| Kennedy Patrick | Director | 3 | 0 | 0 |
| Patil Neena M | Officer · EVP & Chief Legal Officer | 2 | 0 | 1 |
| Pearce Samantha | Officer · EVP, Chief Commercial Officer | 2 | 0 | 0 |
| Mulligan Seamus | Director | 1 | 0 | 0 |
| Johnson Philip L | Officer · EVP & Chief Financial Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Patil Neena M | S (D) | 1,200 | $240.94 | 47,671 | Form 4 |
| 2026-09-08 | Gala Renee D | F (D) | 1,967 | $246.81 | 145,394 | Form 4 |
| 2026-09-08 | Gala Renee D | S (D) | 2,000 | $243.03 | 143,394 | Form 4 |
| 2026-09-08 | Henderson Mary Elizabeth | F (D) | 1,412 | $243.03 | 23,830 | Form 4 |
| 2026-09-08 | Henderson Mary Elizabeth | F (D) | 15 | $241.2 | 23,815 | Form 4 |
| 2026-09-01 | Cozadd Bruce C | S (D) | 6,000 | $250.13 | 351,875 | Form 4 |
| 2026-08-31 | Riedel Norbert G | F (D) | 14 | $244.64 | 8,615 | Form 4 |
| 2026-08-31 | Riedel Norbert G | F (D) | 1,692 | $241.39 | 6,923 | Form 4 |
| 2026-08-31 | Love Ted W | F (D) | 6 | $244.06 | 3,126 | Form 4 |
| 2026-08-31 | Love Ted W | F (D) | 737 | $241.39 | 2,389 | Form 4 |
| 2026-08-31 | Cozadd Bruce C | F (D) | 10 | $244.06 | 359,084 | Form 4 |
| 2026-08-31 | Cozadd Bruce C | F (D) | 1,209 | $241.39 | 357,875 | Form 4 |
| 2026-08-31 | Enright Patrick G | F (D) | 14 | $244.64 | 22,970 | Form 4 |
| 2026-08-31 | Enright Patrick G | F (D) | 1,692 | $241.39 | 21,278 | Form 4 |
| 2026-08-31 | Winningham Rick E | F (D) | 14 | $244.64 | 9,466 | Form 4 |
| 2026-08-31 | Winningham Rick E | F (D) | 1,692 | $241.39 | 9,480 | Form 4 |
| 2026-08-31 | McSharry Heather Ann | F (D) | 15 | $244.64 | 20,039 | Form 4 |
| 2026-08-31 | McSharry Heather Ann | F (D) | 1,840 | $241.39 | 18,199 | Form 4 |
| 2026-08-31 | Hamill Laura | F (D) | 1,692 | $241.39 | 6,832 | Form 4 |
| 2026-08-31 | Hamill Laura | F (D) | 14 | $244.06 | 8,524 | Form 4 |
| 2026-08-31 | Cook Jennifer E. | F (D) | 14 | $244.06 | 12,428 | Form 4 |
| 2026-08-31 | Cook Jennifer E. | F (D) | 1,692 | $241.39 | 10,736 | Form 4 |
| 2026-08-31 | Smith Mark Douglas | F (D) | 14 | $244.64 | 11,271 | Form 4 |
| 2026-08-31 | Smith Mark Douglas | F (D) | 1,692 | $241.39 | 9,579 | Form 4 |
| 2026-08-31 | Henderson Mary Elizabeth | F (D) | 2,076 | $241.39 | 25,258 | Form 4 |
| 2026-08-31 | Henderson Mary Elizabeth | F (D) | 16 | $244.64 | 25,242 | Form 4 |
| 2026-08-31 | Kennedy Patrick | F (D) | 1,840 | $241.39 | 6,452 | Form 4 |
| 2026-08-31 | Kennedy Patrick | F (D) | 15 | $244.06 | 8,292 | Form 4 |
| 2026-08-27 | Iannone Robert | M (A) | 27,584 | $137.12 | 139,691 | Form 4 |
| 2026-08-27 | Iannone Robert | M (A) | 2,916 | $137.12 | 142,607 | Form 4 |
| 2026-08-27 | Iannone Robert | S (D) | 18,187 | $247.86 | 124,420 | Form 4 |
| 2026-08-27 | Iannone Robert | S (D) | 11,423 | $248.67 | 112,997 | Form 4 |
| 2026-08-27 | Iannone Robert | S (D) | 18,113 | $250.02 | 94,884 | Form 4 |
| 2026-08-27 | Iannone Robert | S (D) | 9,259 | $251.95 | 65,986 | Form 4 |
| 2026-08-27 | Iannone Robert | S (D) | 300 | $252.76 | 65,686 | Form 4 |
| 2026-08-27 | Iannone Robert | S (D) | 19,639 | $250.6 | 75,245 | Form 4 |
| 2026-08-27 | Iannone Robert | M (A) | 26,116 | $113.1 | 111,223 | Form 4 |
| 2026-08-27 | Iannone Robert | M (A) | 884 | $113.1 | 112,107 | Form 4 |
| 2026-08-05 | Riedel Norbert G | A (A) | 1,605 | $0 | 8,629 | Form 4 |
| 2026-08-05 | Love Ted W | A (A) | 1,605 | $0 | 3,132 | Form 4 |
| 2026-08-05 | Cozadd Bruce C | A (A) | 1,605 | $0 | 362,287 | Form 4 |
| 2026-08-05 | Enright Patrick G | A (A) | 1,605 | $0 | 22,984 | Form 4 |
| 2026-08-05 | Winningham Rick E | A (A) | 1,605 | $0 | 11,172 | Form 4 |
| 2026-08-05 | Mulligan Seamus | A (A) | 1,605 | $0 | 1,184,633 | Form 4 |
| 2026-08-05 | McSharry Heather Ann | A (A) | 1,605 | $0 | 20,054 | Form 4 |
| 2026-08-05 | Hamill Laura | A (A) | 1,605 | $0 | 8,538 | Form 4 |
| 2026-08-05 | Cook Jennifer E. | A (A) | 1,605 | $0 | 12,442 | Form 4 |
| 2026-08-05 | Smith Mark Douglas | A (A) | 1,605 | $0 | 11,285 | Form 4 |
| 2026-08-05 | Pearce Samantha | F (D) | 780 | $261.62 | 47,131 | Form 4 |
| 2026-08-05 | Kennedy Patrick | A (A) | 1,605 | $0 | 8,307 | Form 4 |
| 2026-08-03 | Cozadd Bruce C | S (D) | 6,000 | $252.98 | 360,682 | Form 4 |
| 2026-07-01 | Cozadd Bruce C | S (D) | 6,000 | $240.47 | 366,682 | Form 4 |
| 2026-06-30 | Gala Renee D | F (D) | 4,835 | $237.72 | 147,361 | Form 4 |
| 2026-06-30 | Iannone Robert | F (D) | 3,764 | $237.72 | 85,107 | Form 4 |
| 2026-06-30 | Patil Neena M | F (D) | 2,678 | $237.72 | 48,871 | Form 4 |
| 2026-06-30 | Pearce Samantha | F (D) | 2,527 | $237.72 | 47,911 | Form 4 |
| 2026-06-30 | Johnson Philip L | F (D) | 3,343 | $237.72 | 56,431 | Form 4 |
Transaction codes in this quarter
Get JAZZ insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1232524&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · JAZZ company page · Jazz Pharmaceuticals plc on SEC.gov
Questions
Are insiders buying or selling Jazz Pharmaceuticals plc (JAZZ)?
In Q3 2026, insiders at Jazz Pharmaceuticals plc reported 57 non-derivative transactions on 34 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $24.4M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Jazz Pharmaceuticals plc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/jazz.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.